LCP
STJ

Legacy Capital Partners’s St Jude Medical STJ Stock Holding History

Legacy Capital Partners’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,320
Closed -$267K – 116
2016
Q4 		$267K Sell
3,320
-500
-13% -$39.7K 0.16% 98
2016
Q3 		$305K Hold
3,820
– – 0.19% 97
2016
Q2 		$298K Sell
3,820
-100
-3% -$7.13K 0.19% 95
2016
Q1 		$216K Hold
3,920
– – 0.14% 106
2015
Q4 		$243K Sell
3,920
-1,100
-22% -$69.4K 0.16% 101
2015
Q3 		$317K Sell
5,020
-300
-6% -$21.4K 0.22% 92
2015
Q2 		$389K Hold
5,320
– – 0.25% 87
2015
Q1 		$348K Buy
+5,320
New +$354K 0.22% 90
2014
Q4 		– Sell
-3,720
Closed -$224K – 120
2014
Q3 		$224K Hold
3,720
– – 0.15% 103
2014
Q2 		$258K Buy
3,720
+100
+3% +$6.48K 0.17% 100
2014
Q1 		$237K Buy
3,620
+20
+0.6% +$1.3K 0.17% 98
2013
Q4 		$224K Buy
+3,600
New +$208K 0.16% 99

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Legacy Capital Partners's STJ Position: Q1 2017 in Review

Legacy Capital Partners sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 3,320 shares — an estimated $267K sold.

Legacy Capital Partners first reported a position in STJ in Q4 2013 and held it in 12 quarters. The position peaked at $389K in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Legacy Capital Partners reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Legacy Capital Partners sold 3,320 St Jude Medical shares in Q1 2017, an estimated $267K.
  • Legacy Capital Partners first reported a position in St Jude Medical in Q4 2013 and held it in 12 quarters.
  • Legacy Capital Partners's St Jude Medical position peaked at $389K in Q2 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Legacy Capital Partners's 13F filing for Q1 2017, filed 9 May 2017.